Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; dermatology products; generic pharmaceutical products; and dentistry products. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Bausch Health Companies Inc.

Brand House Collective ( ($TBHC) ) just unveiled an announcement. Following the closing of a merger effective April 2, 2026, Brand House Collective...

Brand House Collective Completes Merger and Nasdaq Delisting

Brand House Collective ( ($TBHC) ) just unveiled an update. On March 26, 2026, The Brand House Collective disclosed that it had received a Nasdaq n...

Brand House Collective Faces Nasdaq Listing Compliance Challenge

Pathfinder Bancorp ( ($PBHC) ) has issued an announcement. On March 30, 2026, Pathfinder Bancorp, Inc. announced that its board declared a cash div...

Pathfinder Bancorp Declares Quarterly Cash Dividend for Shareholders

Kirkland’s (($TBHC)) has held its Q4 earnings call. Read on for the main highlights of the call. Kirkland’s latest earnings call painted a cautious...

Kirkland’s Earnings Call: Progress Shadowed by Tariff Risks

Brand House Collective ( ($TBHC) ) has issued an announcement. The Brand House Collective, Inc. reported that Chief Operating Officer James E. Schi...

Market Cap	$3.14B	P/E Ratio	1.28
52W High	$8.69	52W Low	$4.25
Div Yield	N/A	Payout Ratio	0.0%
EPS Growth 3Y	63.3%	52W Position	24.1%
Overall Score	42	Value Score	60
Quality Score	50	Technical Score	18

EPS Current Est	$4.15	EPS Next Est	$3.81
EPS Growth Est	-8.2%	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	BHC	$5.32	+1.14%	894.85K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	BHC	$5.32	+1.1%	894.85K
3
4
5
6

BHC

BHC

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Bausch Health Companies Inc. Data in Excel

Get Bausch Health Companies Inc. Data in Excel